Acquiring Company
NeoGenomics
Acquired Company
Pathline
Fort MyersRamseyBiotechnologyHealth CareMedicalHealth DiagnosticsHealth CareDescription
Neogenomics has announced the acquisition of Pathline LLC, a New Jersey-based laboratory specializing in pathology services. This strategic move aims to enhance Neogenomics' presence in the Northeastern United States. Integrating Pathline is expected to contribute positively to Neogenomics' revenue and operational efficiencies. The deal aligns with Neogenomics' expansion strategy without disrupting its existing revenue projections.
Quick answer
NeoGenomics is acquiring Pathline, announced March 10, 2025. NeoGenomics is based in Fort Myers, Florida, United States.
- How much did NeoGenomics pay for Pathline?
- The deal value was not disclosed.
- What does NeoGenomics do?
- Neogenomics is a leading cancer diagnostics company, providing comprehensive laboratory services.
- Where are NeoGenomics and Pathline based?
- NeoGenomics is based in Fort Myers, Florida, United States. Pathline is based in Ramsey, New Jersey, United States.
- Who are the decision-makers at NeoGenomics?
- Fundz holds 1 contact at NeoGenomics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Health Diagnostics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Organon acquires Tofidence biosimilar rights (April 14, 2025)
- Premier Biotech acquires OraSure's testing line (April 10, 2025)
- Globus Medical completes acquisition of Nevro Corp. (April 3, 2025)
- Flourish Research acquires Diablo Clinical Research to expand therapeutic coverage (February 18, 2025)
- NeoGenomics acquires Pathline for Northeast expansion (April 7, 2025)
- Lupin acquires UK-based Renascience Pharma (April 3, 2025)
Who to call at NeoGenomics, and when
When NeoGenomics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day NeoGenomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NeoGenomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NeoGenomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NeoGenomics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Pathline?
Pathline was acquired by NeoGenomics, based in Fort Myers. The deal was reported on March 10, 2025. Neogenomics is a leading cancer diagnostics company, providing comprehensive laboratory services. They specialize in genetic testing and next-generation sequencing to enhance cancer treatment. NeoGenomics is publicly traded (NEO) and operates in Biotechnology.
When did NeoGenomics acquire Pathline?
NeoGenomics's acquisition of Pathline was reported on March 10, 2025. Neogenomics has announced the acquisition of Pathline LLC, a New Jersey-based laboratory specializing in pathology services. This strategic move aims to enhance Neogenomics' presence in the Northeastern United States. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Pathline do?
Pathline LLC is a private laboratory service provider specializing in pathology services. The company has a robust presence in the lab services sector, offering various diagnostic capabilities. It is privately held, operating in Health Care, and is based in Ramsey.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.